As of 2026-04-03, the Intrinsic Value of Huadong Medicine Co Ltd (000963.SZ) is 51.79 CNY. This 000963.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 36.88 CNY, the upside of Huadong Medicine Co Ltd is 40.40%.
The range of the Intrinsic Value is 36.48 - 95.31 CNY
Based on its market price of 36.88 CNY and our intrinsic valuation, Huadong Medicine Co Ltd (000963.SZ) is undervalued by 40.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 36.48 - 95.31 | 51.79 | 40.4% |
| DCF (Growth 10y) | 43.18 - 106.80 | 59.85 | 62.3% |
| DCF (EBITDA 5y) | 37.00 - 44.22 | 41.95 | 13.8% |
| DCF (EBITDA 10y) | 42.99 - 53.83 | 49.46 | 34.1% |
| Fair Value | 11.70 - 11.70 | 11.70 | -68.26% |
| P/E | 27.80 - 45.84 | 33.20 | -10.0% |
| EV/EBITDA | 25.02 - 30.74 | 28.55 | -22.6% |
| EPV | 17.15 - 22.39 | 19.77 | -46.4% |
| DDM - Stable | 23.02 - 83.18 | 53.10 | 44.0% |
| DDM - Multi | 32.37 - 86.82 | 46.68 | 26.6% |
| Market Cap (mil) | 64,677.93 |
| Beta | 0.35 |
| Outstanding shares (mil) | 1,753.74 |
| Enterprise Value (mil) | 62,608.21 |
| Market risk premium | 6.13% |
| Cost of Equity | 7.35% |
| Cost of Debt | 5.00% |
| WACC | 7.20% |